These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 22918496)
1. Sample size calculations: should the emperor's clothes be off the peg or made to measure? Norman G; Monteiro S; Salama S BMJ; 2012 Aug; 345():e5278. PubMed ID: 22918496 [No Abstract] [Full Text] [Related]
2. Neither off the peg nor made to measure calculations are fit for purpose. Pharoah PD BMJ; 2012 Oct; 345():e6585. PubMed ID: 23033421 [No Abstract] [Full Text] [Related]
4. The clinician as investigator: participating in clinical trials in the practice setting: Appendix 2: statistical concepts in study design and analysis. Lader EW; Cannon CP; Ohman EM; Newby LK; Sulmasy DP; Barst RJ; Fair JM; Flather M; Freedman JE; Frye RL; Hand MM; Jesse RL; Van de Werf F; Costa F; Circulation; 2004 Jun; 109(21):e305-7. PubMed ID: 15173053 [No Abstract] [Full Text] [Related]
5. The emperor's new clothes. Brackett CC Crit Care Med; 1992 Dec; 20(12):1740-1. PubMed ID: 1458958 [No Abstract] [Full Text] [Related]
6. Practical guide to sample size calculations: an introduction. Flight L; Julious SA Pharm Stat; 2016; 15(1):68-74. PubMed ID: 26585441 [TBL] [Abstract][Full Text] [Related]
7. Sample size estimation: an overview with applications to orthodontic clinical trial designs. Pandis N; Polychronopoulou A; Eliades T Am J Orthod Dentofacial Orthop; 2011 Oct; 140(4):e141-6. PubMed ID: 21967951 [TBL] [Abstract][Full Text] [Related]
10. Statistical considerations on design and analysis of bridging and multiregional clinical trials. Tsong Y J Biopharm Stat; 2012 Sep; 22(5):1078-80. PubMed ID: 22946952 [No Abstract] [Full Text] [Related]
11. Test for the consistency of noninferiority from multiple clinical trials. Yan X; Wang MC; Su X J Biopharm Stat; 2007; 17(2):265-78. PubMed ID: 17365223 [TBL] [Abstract][Full Text] [Related]
12. On sample size determination in multi-armed confirmatory adaptive designs. Wassmer G J Biopharm Stat; 2011 Jul; 21(4):802-17. PubMed ID: 21516570 [TBL] [Abstract][Full Text] [Related]
13. Blinded sample size recalculation for clinical trials with normal data and baseline adjusted analysis. Friede T; Kieser M Pharm Stat; 2011; 10(1):8-13. PubMed ID: 19943322 [TBL] [Abstract][Full Text] [Related]
14. Adaptive statistical analysis following sample size modification based on interim review of effect size. Hung HM; Cui L; Wang SJ; Lawrence J J Biopharm Stat; 2005; 15(4):693-706. PubMed ID: 16022173 [TBL] [Abstract][Full Text] [Related]
15. Estimands-new statistical principle or the emperor's new clothes? Rosenkranz G Pharm Stat; 2017 Jan; 16(1):4-5. PubMed ID: 27966259 [No Abstract] [Full Text] [Related]
16. Caution regarding the choice of standard deviations to guide sample size calculations in clinical trials. Chen H; Zhang N; Lu X; Chen S Clin Trials; 2013 Aug; 10(4):522-9. PubMed ID: 23794405 [TBL] [Abstract][Full Text] [Related]
17. Methodology of superiority vs. equivalence trials and non-inferiority trials. Christensen E J Hepatol; 2007 May; 46(5):947-54. PubMed ID: 17412447 [TBL] [Abstract][Full Text] [Related]
18. Using aspects of study design in sample size estimation. Phillips A; Campbell M J Biopharm Stat; 1997 May; 7(2):215-26. PubMed ID: 9136065 [TBL] [Abstract][Full Text] [Related]
19. Studying the prevention of acute kidney injury: lessons from an 18th-century mathematician. Chertow GM; Palevsky PM; Greene T Clin J Am Soc Nephrol; 2006 Sep; 1(5):1124-7. PubMed ID: 17699335 [No Abstract] [Full Text] [Related]
20. Missing data in trials: do we have to keep carrying the last observation forward? Boers M Arthritis Rheum; 2008 Jan; 59(1):2-3. PubMed ID: 18163416 [No Abstract] [Full Text] [Related] [Next] [New Search]